EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Intensive combination chemotherapy (TTL-I protocol) of large cell and immunoblastic lymphomas--long-term observation



Intensive combination chemotherapy (TTL-I protocol) of large cell and immunoblastic lymphomas--long-term observation



Neoplasma 39(1): 43-47



Fifty patients with advanced (Stage III and IV) large cell and immunoblastic lymphoma were treated with eight 4-week courses of chemotherapy. The first two identical A courses were composed of high dose cyclophosphamide, vincristine, 5-day administration of bleomycin, 2-week prednisone, and methotrexate with calcium leucovorin. The next two "B" courses were composed of vincristine, 3-day administration of doxorubicin together with bleomycin, and prednisone. The next two "C" courses were composed of cyclophosphamide, vincristine, bleomycin, prednisone, methotrexate, and calcium leucovorin. The last two "D" courses were the same as "B" courses. CNS prophylaxis was done with intrathecal methotrexate. Fourty-two patients (84%) achieved complete remission, 7 patients entered partial remission, and 1 patient failed to respond. The median survival of all groups was 80 + months (range 2-181 + months). Nine patients relapsed (21%), and seven patients died in complete remission, three of them died of toxicity. The most frequent toxicity was myelosuppression, mostly leukopenia, frequently followed by infection, sometimes severe. Neurotoxicity and stomatitis were frequent, but usually not severe. Two patients developed secondary malignancies. Most of the patients (54%) are alive without evidence of disease at present.

(PDF emailed within 1 workday: $29.90)

Accession: 040463080

Download citation: RISBibTeXText

PMID: 1382234



Related references

Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80). Journal of Clinical Oncology 4(2): 147-153, 1986

Impact of involved field radiotherapy after chop-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas. International Journal of Radiation Oncology Biology Physics 48(4): 1107-1110, November 1, 2000

Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy. International Journal of Radiation Oncology Biology Physics 49(1): 17-22, January 1, 2001

New implantable systems in intensive long-term chemotherapy of leukemias and lymphomas. Recenti Progressi in Medicina 76(6): 316-318, 1985

Comparison of long-term clinical outcomes of CHOP chemotherapy between Japanese patients with nodal peripheral T-cell lymphomas and those with diffuse large B-cell lymphoma in the study group of the Tohoku Hematology Forum. Journal of Clinical and Experimental Hematopathology 51(1): 29-35, 2011

Involved field radiotherapy after chop-based chemotherapy improves local control and freedom from progression in patients with bulky, clinical stage III-IV, intermediate grade of large-cell immunoblastic lymphomas. International Journal of Radiation Oncology Biology Physics 48(3 Supplement): 331, 2000

Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor. Blood 89(7): 2291-2297, 1997

Treatment of aggressive primary lymphomas of the digestive system by intensive chemotherapy. Experience of the Study Group on Lymphomas in Adults with the LNH-84 protocol. Annales de Gastroenterologie et D'hepatologie 28(4): 205-208, 1992

Short- and long-term outcomes after large pulmonary resection for germ cell tumors after bleomycin-combination chemotherapy. Annals of Thoracic Surgery 78(4): 1224-8; Discussion 1228-9, 2004

Treatment of acute myeloid leukemia with a combination of intensive induction chemotherapy, early consolidation, splenectomy and long-term maintenance chemotherapy. Cancer 53(8): 1644-1650, 1984

High grade non hodgkins lymphomas long term results of treatment with combination chemotherapy. 1986

T-Cell/Histiocyte-Rich Large B-Cell Lymphomas and Classical Diffuse Large B-Cell Lymphomas Have Similar Responsiveness to Chemotherapy A Matched-Control Analysis on 50 Patients. Blood 100(11): Abstract No 601, November 16, 2002

T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis. Journal of Clinical Oncology 21(7): 1271-1277, 2003